Advertisement

Topics

Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines

2014-07-24 14:20:42 | BioPortfolio

Summary

NT 201 is a Botulinum toxin type A preparation free of complexing proteins, i.e. free of bacterial proteins other than the active toxin. Injected into the muscle, NT 201 causes local weakening. Botulinum toxin type A is widely used for aesthetic treatment of facial lines. This study will investigate the safety and efficacy of NT 201 in the treatment of glabellar frown lines.

Study Design

Allocation: Non-Randomized, Control: Uncontrolled, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Conditions

Glabellar Lines

Intervention

Injection of: NT 201, a Botulinum neurotoxin type A, free of complexing proteins

Location

Skin Care Centre
Los Angeles
California
United States
90069

Status

Completed

Source

Merz Pharmaceuticals GmbH

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-24T14:20:42-0400

Clinical Trials [1509 Associated Clinical Trials listed on BioPortfolio]

NT 201, a Botulinum Toxin Type A Preparation Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

NT 201 is a botulinum toxin type A preparation free of complexing proteins, i.e. free of proteins other than the active toxin. Injected into the muscle, NT 201 causes local weakening. Botu...

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

The purpose of this study is to demonstrate the safety of multiple doses of DWP-450 (Botulinum purified neurotoxin, Type A) Injection in treatment of moderate to severe glabellar lines in ...

NT 201 in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines

NT 201 is a Botulinum toxin type A preparation free of complexing proteins. Injected into the muscle, NT 201 causes a reversible local relexation of the injected muscle. Botulinum toxin ty...

Efficacy and Safety of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

255 female and male patients with moderate to severe glabellar frown lines will be randomized in a 2:1 ratio to receive one injection of NT 201 or placebo and will be followed up until day...

Efficacy and Safety of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines No. 2

255 female and male patients with moderate to severe glabellar frown lines will be randomized in a 2:1 ratio to receive one injection of NT 201 or placebo and will be followed up until day...

PubMed Articles [19582 Associated PubMed Articles listed on BioPortfolio]

Botulinum Toxin as a Treatment for Depression in a Real-world Setting.

A series of randomized controlled trials have shown the efficacy of glabellar botulinum toxin (BTX) injection as a treatment for depression in women. We wanted to extend these findings and assess how ...

Primary treatment of early fistula of parotid duct with botulinum toxin type A injection.

Salivary duct injury can be idiopathic, iatrogenic, or post-trauma and may result in sialocele or fistula. Most injuries regress spontaneously and botulinum toxin A is one of several therapeutic possi...

Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.

Diseases triggered by microorganisms can be controlled by vaccines, which need neutralizing antigens. Hence, it is very crucial to identify extremely efficient immunogens for immune prevention. Botuli...

Differential endopeptidase activity of different forms of type A botulinum neurotoxin: A unique relationship between the size of the substrate and activity of the enzyme.

Botulinum neurotoxins (BoNTs; serotypes A-G) are metalloproteases, which cleave and inactivate cellular proteins essential for neurotransmitter release. In bacterial cultures, BoNTs are secreted as a ...

Role of critical elements in botulinum neurotoxin complex in toxin routing across intestinal and bronchial barriers.

The highly potent botulinum neurotoxin serotype A (BoNT/A) inhibits neurotransmitter release at neuromuscular junctions resulting in flaccid muscle paralysis, respiratory arrest and death. In order to...

Medical and Biotech [MESH] Definitions

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type G. Though it has been isolated from soil, no outbreaks involving this type have been recognized.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type C which is neurotoxic to ANIMALS, especially CATTLE, but not humans. It causes dissociation of ACTIN FILAMENTS.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type D which is neurotoxic to ANIMALS, especially CATTLE, but not humans.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type E which is neurotoxic to humans and animals.

Subtype of CLOSTRIDIUM BOTULINUM that produces botulinum toxin type B which is neurotoxic to humans and animals.

More From BioPortfolio on "Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...


Searches Linking to this Trial